1.Catheter ablation of atrial fibrillation.
Chinese Medical Journal 2013;126(14):2753-2761
2.Catheter Ablation of Ventricular Tachycardia/Fibrillation in a Patient with Right Ventricular Amyloidosis with Initial Manifestations Mimicking Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy.
Fa Po CHUNG ; Yenn Jiang LIN ; Ling KUO ; Shih Ann CHEN
Korean Circulation Journal 2017;47(2):282-285
Differentiating arrhythmogenic right ventricular dysplasia/cardiomyopathy (ARVD/C) from other cardiomyopathies is clinically important but challenging. Although the modified Task Force Criteria can facilitate diagnosis of ARVD/C according to clinical manifestations, histopathological examination plays a pivotal role in excluding other diseases that can mimic ARVD/C. Here, we report a patient with amyloidosis that initially presented similarly to ARVD/C. The diagnosis was confirmed by endomyocardial biopsy, and catheter ablation eliminated the ventricular tachyarrhythmias through an epicardial approach.
Advisory Committees
;
Amyloidosis*
;
Arrhythmogenic Right Ventricular Dysplasia
;
Biopsy
;
Cardiomyopathies
;
Catheter Ablation*
;
Catheters*
;
Diagnosis
;
Humans
;
Tachycardia
;
Tachycardia, Ventricular
3.Intramural Reentrant Ventricular Tachycardia in a Patient with Severe Hypertensive Left Ventricular Hypertrophy.
Chin Yu LIN ; Fa Po CHUNG ; Yenn Jiang LIN ; Shih Ann CHEN
Korean Circulation Journal 2015;45(6):526-530
We describe the case of a patient with severe hypertensive left ventricular hypertrophy and sustained hemodynamically unstable ventricular tachycardia (VT). Entrainment was demonstrated in the electrophysiological study. Activation mapping and pacemapping identified the location of the intramural reentrant VT with the exit site close to the epicardium. However, VT persisted after ablation at the epicardial exit site. Successful ablation was performed endocardially at the corresponding position.
Catheter Ablation
;
Humans
;
Hypertension
;
Hypertrophy, Left Ventricular*
;
Pericardium
;
Tachycardia, Ventricular*
4.Can Genetic Risk Scoring Predict Atrial Fibrillation Ablation Outcomes?
Chin Yu LIN ; Yu Feng HU ; Yenn Jiang LIN ; Shih Ann CHEN
Korean Circulation Journal 2019;49(4):350-352
No abstract available.
Atrial Fibrillation
5.Stroke and Bleeding Risk Assessment in Atrial Fibrillation: Where Are We Now?
Ling KUO ; Yi-Hsin CHAN ; Jo-Nan LIAO ; Shih-Ann CHEN ; Tze-Fan CHAO
Korean Circulation Journal 2021;51(8):668-680
Most important international guidelines recommend the use of CHA 2 DS 2 -VASc and HASBLED scores for stroke and bleeding risk assessments in atrial fibrillation (AF) patients, respectively. The 2020 AF guidelines of European Society of Cardiology have revised the definition of “C: congestive heart failure (HF)” component, and now patients with either HF with reduced ejection fraction or preserved ejection fraction should be assigned 1 point.Hypertrophic cardiomyopathy was also included. Besides, the revised “V: vascular diseases” component included both prior myocardial infarction and “angiographically significant coronary artery disease”. It is important to understand that the stroke and bleeding risks of AF patients were not static and should be re-assessed regularly. A high HAS-BLED score itself should not be the only reason to withhold or discontinue oral anticoagulants, but remind physicians for the corrections of modifiable bleeding risk factors and more regular follow up. In the future, the AF duration and left atrial function may play an important role for personalized evaluation of individual stroke risk while more studies are necessary.
6.Stroke and Bleeding Risk Assessment in Atrial Fibrillation: Where Are We Now?
Ling KUO ; Yi-Hsin CHAN ; Jo-Nan LIAO ; Shih-Ann CHEN ; Tze-Fan CHAO
Korean Circulation Journal 2021;51(8):668-680
Most important international guidelines recommend the use of CHA 2 DS 2 -VASc and HASBLED scores for stroke and bleeding risk assessments in atrial fibrillation (AF) patients, respectively. The 2020 AF guidelines of European Society of Cardiology have revised the definition of “C: congestive heart failure (HF)” component, and now patients with either HF with reduced ejection fraction or preserved ejection fraction should be assigned 1 point.Hypertrophic cardiomyopathy was also included. Besides, the revised “V: vascular diseases” component included both prior myocardial infarction and “angiographically significant coronary artery disease”. It is important to understand that the stroke and bleeding risks of AF patients were not static and should be re-assessed regularly. A high HAS-BLED score itself should not be the only reason to withhold or discontinue oral anticoagulants, but remind physicians for the corrections of modifiable bleeding risk factors and more regular follow up. In the future, the AF duration and left atrial function may play an important role for personalized evaluation of individual stroke risk while more studies are necessary.
8.Catheter Ablation of Peri-Conduit Ventricular Tachycardia in a Patient with Rastelli Procedure for Double Outlet Right Ventricle with Malposition of Great Arteries.
Abigail Louise D TE ; Fa Po CHUNG ; Chin Yu LIN ; Atul PRABHU ; Pi Chang LEE ; Shih Ann CHEN
Korean Circulation Journal 2017;47(4):534-535
No abstract available.
Arterial Switch Operation*
;
Arteries*
;
Catheter Ablation*
;
Catheters*
;
Double Outlet Right Ventricle*
;
Humans
;
Tachycardia, Ventricular*
9.Catheter Ablation of Ventricular Tachycardia in Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy
Fa Po CHUNG ; Chin Yu LIN ; Yenn Jiang LIN ; Shih Lin CHANG ; Li Wei LO ; Yu Feng HU ; Ta Chuan TUAN ; Tze Fan CHAO ; Jo Nan LIAO ; Ting Yung CHANG ; Shih Ann CHEN
Korean Circulation Journal 2018;48(10):890-905
Arrhythmogenic right ventricular dysplasia/cardiomyopathy (ARVD/C) is predominantly an inherited cardiomyopathy with typical histopathological characteristics of fibro-fatty infiltration mainly involving the right ventricular (RV) inflow tract, RV outflow tract, and RV apex in the majority of patients. The above pathologic evolution frequently brings patients with ARVD/C to medical attention owing to the manifestation of syncope, sudden cardiac death (SCD), ventricular arrhythmogenesis, or heart failure. To prevent future or recurrent SCD, an implantable cardiac defibrillator (ICD) is highly desirable in patients with ARVD/C who had experienced unexplained syncope, hemodynamically intolerable ventricular tachycardia (VT), ventricular fibrillation, and/or aborted SCD. Notably, the management of frequent ventricular tachyarrhythmias in ARVD/C is challenging, and the use of antiarrhythmic drugs could be unsatisfactory or limited by the unfavorable side effects. Therefore, radiofrequency catheter ablation (RFCA) has been implemented to treat the drug-refractory VT in ARVD/C for decades. However, the initial understanding of the link between fibro-fatty pathogenesis and ventricular arrhythmogenesis in ARVD/C is scarce, the efficacy and prognosis of endocardial RFCA alone were limited and disappointing. The electrophysiologists had broken through this frontier after better illustration of epicardial substrates and broadly application of epicardial approaches in ARVD/C. In recent works of literature, the application of epicardial ablation also successfully results in higher procedural success and decreases VT recurrences in patients with ARVD/C who are refractory to the endocardial approach during long-term follow-up. In this article, we review the important evolution on the delineation of arrhythmogenic substrates, ablation strategies, and ablation outcome of VT in patients with ARVD/C.
Anti-Arrhythmia Agents
;
Arrhythmogenic Right Ventricular Dysplasia
;
Cardiomyopathies
;
Catheter Ablation
;
Catheters
;
Death, Sudden, Cardiac
;
Defibrillators
;
Epicardial Mapping
;
Follow-Up Studies
;
Heart Failure
;
Humans
;
Prognosis
;
Recurrence
;
Syncope
;
Tachycardia
;
Tachycardia, Ventricular
;
Ventricular Fibrillation
10.The Accuracy and Clinical Applicability of a Sensor Based Electromagnetic Non-fluoroscopic Catheter Tracking System
Shinya YAMADA ; Li Wei LO ; Yenn Jiang LIN ; Shih Lin CHANG ; Fa Po CHUNG ; Yu Feng HU ; Ta Chuan TUAN ; Tze Fan CHAO ; Jo Nan LIAO ; Chin Yu LIN ; Shih Ann CHEN
Korean Circulation Journal 2019;49(1):84-96
BACKGROUND AND OBJECTIVES: The differences between electromagnetic-based mapping (EM) and impedance-based mapping (IM) in 3D anatomical reconstruction have not been fully clarified. We aimed to investigate the anatomical accuracy between EM (MediGuide™) and IM (EnSite Velocity™) systems. METHODS: We investigated 15 consecutive patients (10 males, mean age 58±9 years) who underwent pulmonary veins (PVs) isolation for paroxysmal atrial fibrillation (PAF). Contrast-enhanced computed tomography (CT) image of the left atrium (LA) was acquired before ablation and the 3D geometry of the LA was constructed using EM during ablation procedure. We measured the 4 PV angles between the main trunk of each PV and the posterior LA after field scaling. Additionally, the posterior LA surface area was measured. The variables were compared to those of CT-based geometry. A control group of 40 patients who underwent conventional PVs isolation using IM were also evaluated. RESULTS: The actual and relative changes of EM and CT-based geometry in all PV angles and posterior LA were significantly smaller compared to those of IM and CT-based geometry. Intraclass correlation coefficient (ICC) between EM and CT-based geometry were 0.871 (right superior pulmonary vein [RSPV]), 0.887 (right inferior pulmonary vein [RIPV]), 0.853 (left superior pulmonary vein [LSPV]), 0.911 (left inferior pulmonary vein [LIPV]), and 0.833 (posterior LA). On the other hand, ICC between IM and CT-based geometry were 0.548 (RSPV), 0.639 (RIPV), 0.691 (LSPV), 0.706 (LIPV), and 0.568 (posterior LA). CONCLUSIONS: Image integration with EM enables high accurate visualization of cardiac anatomy compared to IM in PAF ablation.
Atrial Fibrillation
;
Atrial Flutter
;
Catheters
;
Fluoroscopy
;
Hand
;
Heart Atria
;
Humans
;
Magnets
;
Male
;
Pulmonary Veins